Menu Search
Equities

Nephros Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NPJP:FRA

Nephros Inc

Actions
  • Price (EUR)3.20
  • Today's Change-0.10 / -3.03%
  • Shares traded1.00k
  • 1 Year change+110.53%
  • Beta1.4164
Data delayed at least 15 minutes, as of Feb 11 2026 07:27 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

  • Revenue in USD (TTM)17.93m
  • Net income in USD1.48m
  • Incorporated1997
  • Employees31.00
  • Location
    Nephros Inc380 Lackawanna PlSOUTH ORANGE 07079-1704United StatesUSA
  • Phone+1 (201) 343-5202
  • Fax+1 (201) 343-5207
  • Websitehttps://www.nephros.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.